It is worth noting that while removing Lcn2 genetically could be considered a preventive regulation, our antibody treatment protocol was curative, as it was started at 2 months of age when the dystrophic disease peak already took place and caused damage. This evidence concerns the gene LCN2 and glycogen storage disease VI.